1. Home
  2. KIDS vs ASMB Comparison

KIDS vs ASMB Comparison

Compare KIDS & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OrthoPediatrics Corp.

KIDS

OrthoPediatrics Corp.

HOLD

Current Price

$20.88

Market Cap

512.4M

Sector

Health Care

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$26.49

Market Cap

512.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KIDS
ASMB
Founded
2007
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
512.4M
512.1M
IPO Year
2016
2010

Fundamental Metrics

Financial Performance
Metric
KIDS
ASMB
Price
$20.88
$26.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
5
Target Price
$24.67
$44.20
AVG Volume (30 Days)
141.9K
140.4K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.78
EPS
N/A
N/A
Revenue
$98,049,000.00
N/A
Revenue This Year
$14.07
N/A
Revenue Next Year
$11.85
$638.39
P/E Ratio
N/A
N/A
Revenue Growth
37.95
N/A
52 Week Low
$14.42
$18.50
52 Week High
$22.80
$39.71

Technical Indicators

Market Signals
Indicator
KIDS
ASMB
Relative Strength Index (RSI) 62.17 45.20
Support Level $15.66 $21.80
Resistance Level $21.40 $30.36
Average True Range (ATR) 0.97 1.30
MACD 0.09 -0.12
Stochastic Oscillator 82.23 18.77

Price Performance

Historical Comparison
KIDS
ASMB

About KIDS OrthoPediatrics Corp.

OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Share on Social Networks: